Mercury Laboratories Limited Share Price & Technical Analysis
MERCURYLAB · ₹771.5 (0.00%)
Healthcare / Drug Manufacturers - Specialty & Generic
₹771.5
0.00%
Mercury Laboratories Limited engages in manufacturing, selling, exporting, and dealing in various pharmaceutical drugs and medicines for mother and child healthcare in India and internationally. The company offers analgesic, anti-inflammatory, anti-pyretic, anthelmintic, antibiotic, anti-coagulant, anti-platelet, bleeding agent, anti-fungal, anti-hypertensive, anti-malarial, cardiovascular system,…
Price chart
Seasonality
Jun has 4 positive and 1 negative years (last 5 years shown)
1% return in Jun, 4% avg return in past 3 year Jun month.
-2% return in 2026, 3% avg return in past 3 years.
Swipe sideways to see all months →
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Yr | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 26 | -1% | 6% | -15% | 5% | 2% | 1% | – | – | – | – | – | – | -2% |
| 25 | -1% | -4% | -1% | 0% | -1% | 3% | 3% | -3% | 0% | 5% | -2% | -5% | -5% |
| 24 | 19% | -26% | -5% | 1% | 1% | 5% | 4% | -1% | -7% | -7% | -1% | -4% | -22% |
| 23 | 7% | -19% | -7% | 3% | 23% | 5% | -6% | 2% | -4% | -1% | -1% | 32% | 34% |
| 22 | 2% | -15% | -13% | -4% | -12% | -5% | -4% | -6% | 26% | 4% | 61% | -9% | 27% |
Monthly return % by calendar month · historical pattern, not a forecast
Bearish · Downtrend · Neutral
Mercury Laboratories Limited engages in manufacturing, selling, exporting, and dealing in various pharmaceutical drugs and medicines for mother and child healthcare in India and internationally. The company offers analgesic, anti-inflammatory, anti-pyretic, anthelmintic, antibiotic, anti-coagulant, anti-platelet, bleeding agent, anti-fungal, anti-hypertensive, anti-malarial, cardiovascular system, central nervous system, eye, gastro-intestinal system, hypoglycemic/anti-diabetic, multivitamin, protein supplement, respiratory system, anti-allergic, steroids, urinary system, uterine stimulant, and other drugs; and formulations, including tablets, oral liquids, injections, small volume parenterals, and eye/ear drops. It also provides pharmaceutical products for PCOS and uterine disorders, galactagogue, haemostat, iron and vitamins, pain management, preterm labor management, antiemetic, PPI; vitamin K1, zinc supplement, antiallergic, vitamin D3, digestive enzyme, promolact, antipyretic, and childcare, as well as products for gynec, pediatric, surgeon, and physician applications. The company export its products comprising anti-inflammatory, antimalarial, digestive, hypoglycemic, multivitamin, CNS, pain management, gynec, CVS, cough and cold, miscellaneous, and other formulations, as well as antibiotic, antifungal, and antiviral formulations to approximately 25 countries, including the Philippines, Myanmar, Sri Lanka, Vietnam, Cambodia, D.R. Congo, Ghana, Nigeria, Mozambique, Zambia, Kenya, lvory Coast, Mauritania, Burundi, Togo, Guatemala, Costa Rica, Peru, Ecuador, the United Kingdom, the United States, Moldova, and Jamaica. Mercury Laboratories Limited was founded in 1962 and is headquartered in Vadodara, India.
Full AI Q&A, portfolio tracking, and live alerts in the app.
Key metrics
Market cap
₹925.80M
P/E ratio
19.64
52W high
₹976.0
52W low
₹620.6
Volume
5
Related stocks in Healthcare
Ngl Fine-chem Ltd.
₹2,732
Coral Laboratories Ltd.
₹500.1
Frequently asked questions
- What is Mercury Laboratories Limited share price today?
- Mercury Laboratories Limited (MERCURYLAB) last traded around ₹771.5 on StockPro. Prices refresh every few minutes during market hours.
- What technical signals does MERCURYLAB have?
- StockPro monitors breakouts, volume spikes, EMA reversals, and momentum for MERCURYLAB. Download the app for real-time alerts.
- How can I analyze Mercury Laboratories Limited stock?
- Use the price chart, seasonality heatmap, key metrics, and AI insight on this page. For portfolio tracking and push alerts, download StockPro on Android or iOS.